Verastem (VSTM) Assets Average (2012 - 2026)
Verastem's (VSTM) quarterly Assets Average came in at $237.1 million in Q1 2026, up 103.33% year-on-year from $116.6 million in Q1 2025, and up 12.04% quarter-over-quarter from $211.6 million in Q4 2025.
Verastem (VSTM) Assets Average (2012 - 2026) Analysis & Trends
Verastem's Assets Average history runs 15 years deep, the most recent figure standing at $237.1 million for Q1 2026.
- On a quarterly basis, Assets Average rose 103.33% year-over-year to $237.1 million in Q1 2026; TTM through Mar 2026 was $237.1 million, a 103.33% increase from a year earlier, with the FY2025 full-year figure at $174.0 million, up 38.5% from the prior year.
- Assets Average climbed to $237.1 million in Q1 2026 per VSTM's latest filing, from $211.6 million in the prior quarter.
- Across five years, Assets Average topped out at $237.1 million in Q1 2026 and bottomed at $103.1 million in Q4 2022.
- The 5-year median for Assets Average is $116.6 million (2025), against an average of $143.4 million.
- Across the five-year window, Assets Average tumbled 36.91% in 2024 and jumped 103.33% in 2026, its largest moves.
- Year by year, Assets Average stood at $103.1 million in 2022, then jumped by 58.08% to $162.9 million in 2023, then tumbled by 30.06% to $114.0 million in 2024, then jumped by 85.72% to $211.6 million in 2025, then rose by 12.04% to $237.1 million in 2026.
- Per Business Quant, the three latest VSTM Assets Average figures stand at $237.1 million (Q1 2026), $211.6 million (Q4 2025), and $186.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | 237.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 237.13 Mn |
| Dec 31, 2025 | 211.65 Mn |
| Sep 30, 2025 | 186.56 Mn |
| Jun 30, 2025 | 163.98 Mn |
| Mar 31, 2025 | 116.62 Mn |
| Dec 31, 2024 | 113.96 Mn |
| Sep 30, 2024 | 116.06 Mn |
| Jun 30, 2024 | 114.64 Mn |
| Mar 31, 2024 | 136.63 Mn |
| Dec 31, 2023 | 162.94 Mn |
| Sep 30, 2023 | 183.96 Mn |
| Jun 30, 2023 | 156.32 Mn |
| Mar 31, 2023 | 107.96 Mn |
| Dec 31, 2022 | 103.07 Mn |
| Sep 30, 2022 | 105.75 Mn |
| Jun 30, 2022 | 108.28 Mn |
| Mar 31, 2022 | 112.41 Mn |
| Dec 31, 2021 | 110.27 Mn |
| Sep 30, 2021 | 117.88 Mn |
| Jun 30, 2021 | 130.40 Mn |